Lu Gan

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0003-4116-8830

发表论文 117 篇 · 总被引 2082 次 · h-index 22

代表论文

• Inetetamab for injection in combination with vinorelbine weekly or every three weeks in HER2-positive metastatic breast cancer: A multicenter, randomized, phase II clinical trial (2024 · Journal of Translational Internal Medicine · 被引 20)
• Altered Visuomotor Network Dynamics Associated with Freezing of Gait in Parkinson's Disease (2025 · Movement Disorders · 被引 12)
• Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial (2025 · 癌症：英文版 · 被引 11)
• Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 9)
• Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 5)
• Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: a real-world study (2024 · International Journal of Surgery · 被引 5)